A detailed history of Oak Associates LTD transactions in Incyte Corp stock. As of the latest transaction made, Oak Associates LTD holds 19,522 shares of INCY stock, worth $1.37 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
19,522
Previous 19,522 -0.0%
Holding current value
$1.37 Million
Previous $1.18 Million 9.04%
% of portfolio
0.09%
Previous 0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$56.55 - $66.59 $1.1 Million - $1.3 Million
19,522 New
19,522 $1.11 Million
Q3 2023

Nov 13, 2023

SELL
$57.77 - $65.93 $113,575 - $129,618
-1,966 Reduced 7.11%
25,685 $1.48 Million
Q2 2023

Aug 11, 2023

BUY
$60.95 - $75.51 $1.69 Million - $2.09 Million
27,651 New
27,651 $1.72 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.7B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Oak Associates LTD Portfolio

Follow Oak Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Associates LTD , based on Form 13F filings with the SEC.

News

Stay updated on Oak Associates LTD with notifications on news.